Form 4 for MPT MEDICAL PROPERTIES TRUST INC
Accepted 2025-04-17 00:00:00 ET · period of report 2025-04-15 · accession 0000950170-25-055631 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-17 | 2025-04-15 | MPT | HAMNER R STEVEN | EVP, CFO, Dir | F - Tax | $3.86 | -5,584 | 2.53M | -0.2% | -$21.6K |
| D | 2025-04-17 | 2025-04-15 | MPT | HAMNER R STEVEN | EVP, CFO, Dir | A - Grant | $0.00 | +494.0K | 3.02M | +20% | $0 |
| D | 2025-04-17 | 2025-04-15 | MPT | HAMNER R STEVEN | EVP, CFO, Dir | A - Grant | $0.00 | +207.0K | 1.11M | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2025-04-15 | F | D | 5,584 | $3.86 | 2,529,963 | D | — | — | (F1) Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. (F2) The total amount of securities beneficially owned following the reported transaction includes a decrease of 117,282 shares as a result of forfeitures related to previously disclosed share awards. |
| 2 | Common | Common stock, par value $0.001 | 2025-04-15 | A | A | 494,026 | $0.00 | 3,023,989 | D | — | — | (F3) Shares vest at the beginning of each calendar quarter ending March 31, 2028. |
| 3 | Derivative | Restricted common stock units | 2025-04-15 | A | A | 207,020 | $0.00 | 1,107,020 | D | $0.00 · — to — | 207,020 Common stock, par value $0.001 | (F5) Earned restricted stock units will be settled in cash (based on the average price of the Company's common stock over the five trading days ending on the applicable vesting date) in equal quarterly installments over one year following the date the restricted stock units are earned, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date. (F4) The restricted stock units were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period beginning April 15, 2025 (the "Grant Date") as follows: (i) if the Company's TSR reaches 20%, 100% of the restricted stock units will be earned; (ii) if the Company's TSR reaches 40%, 200% of the restricted stock units will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 5). |